These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 13978)

  • 1. N-Hydroxylation of pentobarbital in man.
    Tang BK; Inaba T; Kalow W
    Drug Metab Dispos; 1977; 5(1):71-4. PubMed ID: 13978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-hydroxyamobarbital: the second major metabolite of amobarbital in man.
    Tang BK; Inaba T; Kalow W
    Drug Metab Dispos; 1975; 3(6):479-86. PubMed ID: 1222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the metabolites of trichlorocarbanilide in the rat.
    Warren JT; Allen R; Carter DE
    Drug Metab Dispos; 1978; 6(1):38-44. PubMed ID: 23272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of phenobarbital in man. N-Glucoside formation.
    Tang BK; Kalow W; Grey AA
    Drug Metab Dispos; 1979; 7(5):315-8. PubMed ID: 40773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers.
    Polsky-Fisher SL; Vickers S; Cui D; Subramanian R; Arison BH; Agrawal NG; Goel TV; Vessey LK; Murphy MG; Lasseter KC; Simpson RC; Vega JM; Rodrigues AD
    Drug Metab Dispos; 2006 Jun; 34(6):1004-11. PubMed ID: 16510541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of bepridil in laboratory animals and humans.
    Wu WN; Hills JF; Chang SY; Ng KT
    Drug Metab Dispos; 1988; 16(1):69-77. PubMed ID: 2894958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of aminoglutethimide in humans. Identification of four new urinary metabolites.
    Foster AB; Griggs LJ; Howe I; Jarman M; Leung CS; Manson D; Rowlands MG
    Drug Metab Dispos; 1984; 12(4):511-6. PubMed ID: 6148221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
    Colizza K; Awad M; Kamel A
    Drug Metab Dispos; 2007 Jun; 35(6):884-97. PubMed ID: 17360832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
    Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW
    Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norethynodrel metabolites in human plasma and urine.
    Cook CE; Twine ME; Tallent CR; Wall ME; Bressler RC
    J Pharmacol Exp Ther; 1972 Oct; 183(1):197-205. PubMed ID: 5080031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation and elimination of 14C-flecainide acetate in humans.
    McQuinn RL; Quarfoth GJ; Johnson JD; Banitt EH; Pathre SV; Chang SF; Ober RE; Conard GJ
    Drug Metab Dispos; 1984; 12(4):414-20. PubMed ID: 6148206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 4th communication: metabolism in rats and dogs.
    Hirota T; Nakamura A; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):175-81. PubMed ID: 9079237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism of DL-[14C]verapamil in man.
    Eichelbaum M; Ende M; Remberg G; Schomerus M; Dengler HJ
    Drug Metab Dispos; 1979; 7(3):145-8. PubMed ID: 38084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
    Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
    Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.